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Abstract 
The kinetic properties of MSS4 are studied in comparison with those of Rab3A GRF. MSS4 stimulates the dissociation of [3H]GDP from the 
lipid-modified and lipid-unmodified forms of Rab3A to the same extent, although Rab3A GRF is more effective on the lipid-modified form than 
on the lipid-unmodified form. Both MSS4 and Rab3A GRF are inactive on other RablSecl Ypt family members including at least Rab2, Rab5, and 
Rabll. Rab GDI inhibits the MSS4 and Rab3A GRF effects on the lipid-modified form of Rab3A, but the doses of Rab GDI necessary for this 
inhibitory effect on Rab3A GRF are lower than those on MSS4. Moreover, Rab GDI slightly inhibits the Rab3A GRF effect on the lipid-unmodified 
form of Rab3A, but does not affect he MSS4 effect on the lipid-unmodified form of Rab3A. These results uggest that MSS4 and Rab3A GRF are 
different GDP/GTP exchange proteins for Rab3A. 
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I. Introduction 
The Rab/Sec/Ypt small G protein 3 family regulates 
intracel lular vesicle t ransport  such as exocytosis, endocy- 
tosis, and transcytosis (for reviews, see [1-6]). Most  of  
the Rab/Sec/Ypt family members terminate in either of  
two sequences: Cys-Cys or Cys-X-Cys (where X is alan- 
ine, serine, or  glycine). These cysteine residues are ger- 
anylgeranylated and the C-terminal  cysteine of  the Cys- 
X-Cys structure is carboxylmethylated.  
These small G proteins have two interconvertible 
forms: GDP-bound inactive and GTP-bound active 
forms [3]. The GDP-bound form is converted to the 
GTP-bound form by the GDP/GTP  exchange reaction 
which is regulated by GEPs [3]. MSS4 has been isolated 
as a mammal ian  counterpart  of  yeast DSS4 [7], which 
has been isolated as a GEP  for Sec4 [8]. Both recombi-  
nant DSS4 and MSS4 st imulate the GDP/GTP  exchange 
react ion of  Sec4, but their detai led substrate specificities 
have not been studied. Rab3A GRF has been part ial ly 
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purified from rat brain as a GEP  for Rab3A [9], which 
is involved in regulated secretion, part icular ly in neuro- 
transmitter elease [10-13]. Rab3A GRF is active on 
both the l ipid-modif ied and l ip id-unmodif ied forms of  
Rab3A, but is far more active on the former form than 
on the latter form [14]. However, requirement of  MSS4 
for the lipid modif icat ions of  its substrate small G pro-  
tein has not been studied. 
In contrast  o MSS4 and Rab3A GRF,  Rab GDI  is an 
inhibitory GEP  for all the RablSec/Ypt family members 
thus far tested [15-19]. Moreover,  Rab GDI  regulates the 
cyclical t ranslocat ion of  its substrate small G proteins 
between the membrane and the cytosol [20]. Rab GDI  is 
active only on the l ipid-modif ied form of  its substrate 
small G proteins [21]. Rab GDI  inhibits the Rab3A 
GRF-s t imu lated  GDP/GTP  exchange reaction of  
Rab3A, but the sensitivity of  MSS4 to Rab GDI  has not 
been studied. 
In the present study, we have examined here the sub- 
strate specificity, l ipid-requirement, and sensitivity to 
Rab GDI  of  recombinant  MSS4 in compar ison with 
those of  part ial ly purif ied Rab3A GRF.  
2. Materials and methods 
2.1. Materials and chemicals 
Human Rab2 and canine Rab5 were kindly provided by Dr. S. Orita, 
Shionogi Institute for Medical Science, Settsu, Japan, and Dr. M. 
Zerial, European Molecular Biology Laboratory, Heidelberg, Ger- 
many, respectively. Rab3A, RhoA, Racl, and c-Ha-Ras were expressed 
in Spodoptera frugiperda cells (Sf9 cells) and the lipid-modified and 
lipid-unmodified forms were purified from the membrane and soluble 
fractions, respectively, of the cells overexpressing each small G protein 
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[22]. Rab2, Rab3A, Rab5, and Rabl 1 were purified from E. coli which 
overexpressed ach small G protein as a fusion protein with N-terminal 
GST [23]. Rab3A GRF was partially purified from rat brain as de- 
scribed [9]. Rab GDI was purified from bovine brain as described [15]. 
[35S]GTPyS (44.4 TBq/mmol) was purchased from Du Pont- 
New England Nuclear. [3H]GDP (518 GBq/mmol) was purchased from 
Amersham Corp. Nitrocellulose filters (BA-85, 0.45 gm pore size) 
were obtained from Schleicher and Schuell. 
2.2. Expression and purification of MSS4 in E. coli 
The expression plasmid pGEX-2T-MSS4 was constructed as follows. 
The 1.7-kilobase fragment coding for the complete MSS4 cDNA with 
the BamHI and Kpnl sites upstream of the initiator methionine codon 
and downstream of the termination codon was obtained by a polym- 
erase chain reaction from the rat brain cDNA library previously used 
[24]. This fragment was digested by BamHI and inserted into the 
BamHI site of pGEX-2T vector (Pharmacia Biotech Inc.) and expressed 
as a fusion protein with N-terminal GST. E. coli MCI061 transformed 
with pGEX-2T-MSS4 was cultured and treated with 1 mM isopropyl- 
fl-D-thiogalactopyranoside to induce production of GST-MSS4. GST- 
MSS4 was purified by glutathione-Sepharose 4B column chromatogra- 
phy as described [23]. The GST carrier was cleaved off from MSS4 by 
digestion with thrombin as described [23]. Purified MSS4 was dialyzed 
against 50 mM HEPES/NaOH at pH 8.0 containing 100 mM NaCI, 5 
mM MgCI2, and 1 mM EDTA, and stored at -80°C until use. 
2.3. Assays 
The dissociation of [3H]GDP from the small G protein to be tested 
was assayed by measuring the radioactivity of [3H]GDP bound to the 
small G protein after incubation with MSS4, Rab3A GRF, or Rab GDI 
by the filtration method using a nitrocellulose filter as described previ- 
ously [14]. The activity of MSS4 to stimulate the binding of [35S]GTPyS 
to the small G protein to be tested was similarly assayed. 
3. Results 
MSS4 stimulated the dissociation of [3H]GDP from 
and the binding of [35S]GTPyS to the lipid-modified form 
of Rab3A in a time-dependent manner (Fig. 1). The time 
courses for these two reactions were similar. These activ- 
ities of MSS4 were dependent on its doses and the doses 
necessary for these activities were similar (Fig. 2). The 
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Fig. l. Effect of MSS4 on the dissociation of [3H]GDP from and the 
binding of [35S]GTPyS to Rab3A. The velocities of the dissociation of 
[3H]GDP from and the binding of [35S]GTPyS to Rab3A (2 pmol) were 
assayed in the presence or absence of MSS4 (20 pmol). (A) The disso- 
ciation of [3H]GDP from Rab3A. (B) The binding of [35S]GTPyS to 
Rab3A. (0) In the presence of MSS4; (©) in the absence of MSS4. The 
results hown are representative of three independent experiments. 
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Fig. 2. Dose-dependent effect of MSS4 on Rab3A. The dissociation of 
[3H]GDP from and the binding of [35S]GTPyS to Rab3A (2 pmol) were 
assayed for 10 min at 30°C in the presence of various doses of MSS4. 
(A) The dissociation of [3H]GDP from Rab3A. (B) The binding of 
[35S]GTPyS to Rab3A. The results shown are representative of three 
independent experiments. 
dose o f  MSS4 giv ing ha l f  max imum dissoc iat ion o f  
[3H]GDP f rom Rab3A was about  0.4 t iM  and the dose 
o f  MSS4 giv ing hal f  max imum binding o f  [35S]GTPTS to 
Rab3A was also about  0.4 t iM .  
We have prev ious ly  shown that Rab3A GRF is act ive 
on both  the l ip id-modi f ied and l ip id -unmodi f ied forms 
of  Rab3A but  is more  active on the l ip id-modi f ied fo rm 
than on the l ip id -unmodi f ied fo rm [14]. Consistent ly,  
Rab3A GRF was active on the both  forms but  was more  
active on the l ip id-modi f ied fo rm than on the l ip id-un- 
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Fig. 3. Sensitivity of MSS4 and Rab3A GRF to the lipid-modified and 
lipid-unmodified forms of Rab3A. The dissociation of [3H]GDP from 
the lipid-modified form or lipid-unmodified form of Rab3A (2 pmol 
each) was assayed for 10 min at 30°C in the presence of various doses 
of MSS4 or Rab3A GRF. (A) With Rab3A GRF. (B) With MSS4. (0) 
With the lipid-modified form; (©) with the lipid-unmodified form. The 
results shown are representative of three independent experiments. 
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modified form (Fig. 3A). In contrast, MSS4 was equally 
active on both the lipid-modified and lipid-unmodified 
forms (Fig. 3B). 
We have previously shown that Rab GDI inhibits the 
Rab3A GRF-induced GDP/GTP exchange reaction of 
the lipid-modified form of Rab3A but shows far less 
effect on the lipid-unmodified form [14]. Rab GDI inhib- 
ited not only the effect of Rab3A GRF on the lipid- 
modified form of Rab3A but also that of MSS4, but the 
doses of Rab GDI necessary for this inhibitory effect on 
Rab3A GRF were lower than those on MSS4 (Fig. 4A). 
Moreover, Rab GDI slightly inhibited the Rab3A GRF 
effect on the lipid-unmodified form of Rab3A, but did 
not affect he MSS4 effect on the same form of Rab3A 
(Fig. 4B). 
It has previously been shown that MSS4 enhances the 
dissociation of [3H]GDP from the lipid-unmodified form 
of Rab3A but is inactive on the lipid-unmodified form of 
yeast Ras2 [7]. Consistently, MSS4 was active on the 
lipid-unmodified form of Rab3A (Fig. 5) and was inac- 
tive on the same form of c-Ha-Ras, RhoA, and Racl 
(data not shown). Moreover, MSS4 was inactive on the 
same form of other Rab family members including Rab2, 
Rab5, and Rabl 1 (Fig. 5). Rab3A GRF showed similar 
substrate specificity (data not shown). 
4. Discussion 
We have previously shown that one group of GEPs, 
such as Sos for the Ras family members [25], Cdc25 for 
the Ras family members [24], Dbl for the Rho family 
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Fig. 4. Effect of Rab GDI on the MSS4 and Rab3A GRF actions. The 
activity of Rab GDI to inhibit the dissociation of [3H]GDP from the 
lipid-modified form or lipid-unmodified form of Rab3A (2 pmol each) 
was assayed in the presence or absence of MSS4 (20 pmol) or Rab3A 
GRF (4/zg of protein). (A) With the lipid-modified form. (B) With the 
lipid-unmodified form. (O) Without MSS4 and Rab3A GRF; (e)  with 
MSS4; (&) with Rab3A GRF. The results hown are representative of 
three independent experiments. 
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Fig. 5. Substrate specificity of MSS4. The dissociation of [3H]GDP from 
and the binding of [35S]GTPTS to each small G protein (2 pmol) were 
assayed in the presence of various doses of MSS4. (A) The dissociation 
of [3H]GDP. (B) The binding of [35S]GTP~'S. (O) With Rab2; (e)  with 
Rab3A; (A) with Rab5; (A), with Rabl 1. The results hown are repre- 
sentative of three independent experiments. 
members, the Rac family members, and Cdc42 [26], and 
Rab3A GRF for Rab3A [14], are active on both the 
lipid-modified and lipid-unmodified forms of their re- 
spective substrate small G proteins but prefer the lipid- 
modified form to the lipid-unmodified form, whereas 
another group of GEPs, such as Smg GDS for Ki-Ras, 
Rap 1, the Rho family members, the Rac family members, 
and Cdc42 [22,26,27], Rho GDI for the Rho family mem- 
bers, the Rac family members, and Cdc42 [27,28], and 
Rab GDI for the Rab family members [21], absolutely 
require the lipid-modifications of their respective sub- 
strate small G proteins and are totally inactive on the 
lipid-unmodified form. In contrast to these two groups 
of GEPs, we have shown here that MSS4 is equally active 
on both the lipid-modified and lipid-unmodified forms 
of Rab3A. It is likely that MSS4 may belong to the third 
group of GEPs in terms of the requirement of the lipid- 
modifications. 
As to the relationship between MSS4 and Rab3A 
GRF, the definitive conclusion could not be made here 
because Rab3A GRF has only partially been purified 
and its primary structure has not been determined. How- 
ever, we have shown here that MSS4 and Rab3A GRF 
show different properties including the requirement of 
the lipid-modifications of Rab3A and the sensitivity to 
Rab GDI. These results uggest that MSS4 is a different 
molecule from Rab3A GRF. 
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